Literature DB >> 11641428

Allosteric effects of G protein overexpression on the binding of beta-adrenergic ligands with distinct inverse efficacies.

M Azzi1, G Piñeyro, S Pontier, S Parent, H Ansanay, M Bouvier.   

Abstract

Allosteric models of G protein-coupled receptors predict that G protein influences the spontaneous isomerization between inactive (R) and active (R*) conformations. Since inverse agonists have been proposed to preferentially bind to the inactive and uncoupled form(s), changes in the G protein content should influence the binding properties of these ligands. To test this hypothesis, we systematically assessed the effect of G proteins on the binding of beta(2)-adrenergic ligands with distinct levels of inverse efficacy. Recombinant baculoviruses encoding the human beta(2)-adrenoreceptor (beta(2)AR) were expressed alone or in combination with G protein subunits in Sf9 cells. Coexpression with the G protein alpha s beta 1 gamma 2 did not influence the relative efficacy of the ligands to inhibit the adenylyl cyclase but induced considerable decrease in number of sites detected by [(3)H]ICI 118551, [(3)H]propranolol, and (125)I-cyanopindolol. This loss was proportional to the inverse efficacy of the ligand used as the radiotracer in the assay. The addition of Gpp(NH)p inhibited the effects of G protein overexpression indicating that the G proteins acted allosterically. Consistent with this notion, Western blot analysis revealed that coexpression with the G proteins was not accompanied by a loss of immunoreactive beta(2)AR. Such allosteric effects of the G proteins were also observed in mammalian cells expressing endogenous level of G proteins indicating that the phenomenon is not unique to overexpression systems. Taken together, these results demonstrate that the apparent receptor number detected by radiolabeled inverse agonists is affected by the content in G proteins as a result of their influence on R/R* isomerization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641428     DOI: 10.1124/mol.60.5.999

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

2.  Targeted transgenesis identifies Gαs as the bottleneck in β2-adrenergic receptor cell signaling and physiological function in airway smooth muscle.

Authors:  Wayne C H Wang; Susan H Pauer; Dan'elle C Smith; Madison A Dixon; David J Disimile; Alfredo Panebra; Steven S An; Blanca Camoretti-Mercado; Stephen B Liggett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

3.  The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.

Authors:  Xiao Jie Yao; Gisselle Vélez Ruiz; Matthew R Whorton; Søren G F Rasmussen; Brian T DeVree; Xavier Deupi; Roger K Sunahara; Brian Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

4.  Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts.

Authors:  Rhonda L Carter; Laurel A Grisanti; Justine E Yu; Ashley A Repas; Meryl Woodall; Jessica Ibetti; Walter J Koch; Marlene A Jacobson; Douglas G Tilley
Journal:  Pharmacol Res Perspect       Date:  2014-02

5.  G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning.

Authors:  Lauriane Onfroy; Ségolène Galandrin; Stéphanie M Pontier; Marie-Hélène Seguelas; Du N'Guyen; Jean-Michel Sénard; Céline Galés
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

6.  A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes.

Authors:  Martin C Michel; Martina B Michel-Reher; Peter Hein
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

Review 7.  Genetically encoded fluorescent biosensors for GPCR research.

Authors:  Hyunbin Kim; In-Yeop Baek; Jihye Seong
Journal:  Front Cell Dev Biol       Date:  2022-09-29

8.  Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor.

Authors:  Tomomi Sato; Jillian Baker; Tony Warne; Giles A Brown; Andrew G W Leslie; Miles Congreve; Christopher G Tate
Journal:  Mol Pharmacol       Date:  2015-09-18       Impact factor: 4.436

9.  Propranolol attenuates calorie restriction- and high calorie diet-induced bone marrow adiposity.

Authors:  Kyunghwa Baek; Hyun-Jung Park; Hyo Rin Hwang; Jeong-Hwa Baek
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.